Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2005
06/23/2005US20050136454 Cell-signaling assays
06/23/2005US20050136450 Preparing drug model for treatments which target nervous system disorders; rational drug design
06/23/2005US20050136449 For polypeptides having polyhistidine/polycysteine tags; cell extracts comprising nuclease inhibitors; kits
06/23/2005US20050136444 Drug screening
06/23/2005US20050136433 Using mutation in intron-exon boundary of dihydropyrimidine dehydrogenase as indicator for modifying cancer treatment protocol
06/23/2005US20050136432 Using microarray comprising mycobacterium genomic sequences as tool in diagnosing mycobacterial disease; high throughput assay
06/23/2005US20050136431 Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
06/23/2005US20050136429 SIRT1 modulation of adipogenesis and adipose function
06/23/2005US20050136423 Using electrodes comprising immobilized probes as tools in monitoring hybridization preferential DNA/RNA sequences; voltametric multichannel measurements using microelectrode arrays; electroanalysis
06/23/2005US20050136416 Patient specific array-based assays
06/23/2005US20050136409 comprising biopolymer-coated erythrocytes simulating a component of blood samples, obtained by binding biopolymers to the external surface of cells, the biopolymers comprising nucleic acids, peptide nucleic acids, or mucopolysaccharides; used in cytometer or analysis apparatus
06/23/2005US20050136405 Using urogenital smear as tool in detection of tumor marker protein in uterine tissue, fluids an/or cells
06/23/2005US20050136403 Molecular characterists of non-small cell lung cancer
06/23/2005US20050136401 Method and device for detecting feline immunodeficiency virus
06/23/2005US20050136400 NS3-NS4A protease resistance mutants
06/23/2005US20050136399 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
06/23/2005US20050136398 Contacting a candidate compound having an esterified phosphonate or carboxyl group with GS-9005 ester hydrolase B and identifying the compound as a suitable prodrug by the presence of a phosphonic acid or carboxylic acid group; particularly identifying compounds having therapeutic activity against HIV
06/23/2005US20050136397 Methods and compositions for identifying therapeutic compounds
06/23/2005US20050136396 Contacting a candidate compound having an esterified phosphonate or carboxyl group with GS-9005 ester hydrolase A and identifying the compound as a suitable prodrug by the presence of a phosphonic acid or carboxylic acid group; particularly identifying compounds having therapeutic activity against HIV
06/23/2005US20050136258 Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
06/23/2005US20050136177 Method for coloring landscaping materials using foamable dry colorant
06/23/2005US20050136069 Immunogenic portion of Mycobacterium tuberculosis proteins and monophosphoryl lipid A as adjuvant; vaccines
06/23/2005US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines
06/23/2005US20050136054 Humanised antibodies
06/23/2005US20050136051 Mixing a first molecule comprising IgG4 antibody heavy chain fragments capable of forming hinge region intra-heavy chain disulfide bonds with a second molecule comprising IgG4 antibody heavy chain fragments capable of forming hinge region intra-heavy chain disulfide bonds; incubating
06/23/2005US20050136048 Electrochemiluminescence assays; aqueous reagent composition consisting of water, tripropylamine 50 mM-1000 mM and an electrolyte comprising a pH buffer selected from tris(hydroxymethyl)aminomethane and glycylglycine, pH of 6.5-8.5; improved sensitivity
06/23/2005US20050136047 Hapten-carrier conjugates for treating and preventing nicotine addiction
06/23/2005US20050136039 Can exhibit decreased expression of: fatty acid synthase (FAS), adipogenic transcription factors SREBP-1c or C/EBP alpha , beta 3 adrenergic receptor, and fatty acid transport protein 1 (FATP1); use drug screening; prognosis of obesity; diabetes; reduction of insulin receptor signaling
06/23/2005US20050135970 Hydrogen sulfide monitoring system
06/23/2005US20050135969 Method and apparatus for determining indirectly the concentration of a specific substance in the blood
06/23/2005US20050135968 Plastic injection-moulded part with embedded component
06/23/2005US20050135966 Device and method for detecting harmful gases using a carbon dioxide sensor
06/23/2005US20050135964 Carrier medium for analyzing a substance
06/23/2005US20050135723 Optical substance analyzer
06/23/2005US20050135101 Solar powered light assembly to produce light of varying colours
06/23/2005US20050134833 Method and apparatus for measuring cell-by-cell hemoglobin
06/23/2005US20050133716 Explosives detection using differential ion mobility spectrometry
06/23/2005US20050133715 Matrix with noise reduction additive and disposable target containing the same
06/23/2005US20050133697 Sensor devices containing co-polymer substrates for analysis of chemical and biological species in water and air
06/23/2005US20050133425 Sample preparation of biological fluids for proteomic applications
06/23/2005US20050133368 Electrochemical test strip for reducing the effect of direct interference current
06/23/2005US20050133261 Formation fluid characterization using flowline viscosity and density data an oil-based mud environment
06/23/2005US20050133013 Software fuel volatility measurement
06/23/2005US20050132970 Probes for myctophid fish and a method for developing the same
06/23/2005US20050132827 Carrier tube for sensors
06/23/2005US20050132823 Sampling device
06/23/2005US20050132783 Rheometer
06/23/2005US20050132782 Rheomixer device
06/23/2005US20050132776 Method and apparatus for measuring gas concentration levels in liquids
06/23/2005US20050132774 Device and method for transferring a reference liquid into a measurement appliance
06/23/2005DE20023640U1 Detecting an embryonic cell surface marker e.g. cartilage-derived morphogenic protein CDMP-1 so as to positively identify viable precursor cells that have entered a post-natal differentiation pathway
06/23/2005DE10362048A1 Vorrichtung zur Bestimmung und/oder Überwachung der Schichtdicke eines flüssigen Mediums Device for determining and / or monitoring of the layer thickness of a liquid medium
06/23/2005DE10356130A1 Neue Polymethinfarbstoffe auf Cumarin-Basis mit einstellbarem Stokes-Shift New polymethine dyes coumarin-base with adjustable Stokes shift
06/23/2005DE10354403A1 Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung Against the prothrombin fragment 1 + F 2 directed antibody, their preparation and use
06/23/2005DE10353938A1 Sensorkarte zur Bestimmung von Analyten in Flüssigkeits- oder Gasproben und Verfahren zur Herstellung einer solchen Sensorkarte Sensor card for the determination of analytes in liquid or gas sample and methods for producing such a sensor card
06/23/2005DE10353803A1 Diagnostische, prognostische und therapeutische Verfahren bei der Untersuchung und Therapie maligner Tumoren Diagnostic, prognostic and therapeutic procedures in the investigation and treatment of malignant tumors
06/23/2005DE10353593A1 Leptinantagonist und Verfahren zur quantitativen Messung von Leptin Leptin antagonist and method for quantitative measurement of leptin
06/23/2005DE10353276A1 Process to predict the likely carcinogenic effect of a virus on man by exposure of fish to the same agent
06/23/2005DE10353019A1 Process and assembly to determine the characteristics of ground water in an elongated geological filtration strata
06/23/2005DE10351492A1 Medical laboratory diagnosis of inflammatory central nervous system disease, e.g. multiple sclerosis, involves nephelometric measurement of free lambda immunoglobin light chains in cerebrospinal liquor of patient
06/23/2005DE10304688B4 Verfahren und Vorrichtung zur Prüfung der Teilbarkeit und Teilgenauigkeit von Tabletten Method and apparatus for testing the divisibility and part accuracy of tablets
06/23/2005DE10233901B4 Messvorrichtung mit Einstechelektrode Measuring device with Einstechelektrode
06/23/2005DE102004057203A1 Gasmessfühler Gas Sensor
06/23/2005DE10162814B4 Rekonstruiertes Haarfollikelmodell Reconstructed hair follicle
06/23/2005CA2832293A1 Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
06/23/2005CA2643922A1 The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
06/23/2005CA2561746A1 Methods and compounds for modulating triglyceride and vldl secretion
06/23/2005CA2554215A1 Multiparameter system for environmental monitoring
06/23/2005CA2552435A1 Inhibitors of type 2 vascular endothelial growth factor receptors
06/23/2005CA2549691A1 Seal for measuring device
06/23/2005CA2549482A1 Megsin/rage/inos overexpressing renaldisease model animals and methods for evaluating compounds using the model animals
06/23/2005CA2549391A1 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
06/23/2005CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
06/23/2005CA2549291A1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/23/2005CA2549236A1 Risk markers for cardiovascular disease
06/23/2005CA2548882A1 Methods and systems for analyzing and determining ligand-residue interaction
06/23/2005CA2548817A1 Methods of generating variant proteins with increased host string content and compositions thereof
06/23/2005CA2548813A1 Antibodies that specifically bind pms2
06/23/2005CA2548812A1 Detection of conformationally altered proteins and prions
06/23/2005CA2548750A1 Lawsonia intracellularis 26 kd subunit vaccine
06/23/2005CA2548530A1 Charcoal stabilization of phenyl phosphates
06/23/2005CA2548496A1 A computer based versatile method for identifying protein coding dna sequences useful as drug targets
06/23/2005CA2548495A1 Interaction of nmda receptor with the protein tyrosine phosphatase step in psychotic disorders
06/23/2005CA2548254A1 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
06/23/2005CA2548252A1 Use of siloxane-based polymers or composites in chemical sensors for detecting nitrate compounds
06/23/2005CA2548180A1 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
06/23/2005CA2548015A1 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse
06/23/2005CA2547869A1 Methods of protecting against radiation using flagellin
06/23/2005CA2547861A1 Serum biomarkers for chagas disease
06/23/2005CA2547418A1 Site selectively tagged and templated molecularly imprinted polymers for sensor applications
06/23/2005CA2547072A1 Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
06/23/2005CA2546600A1 Retaining clip for reagent test slides
06/23/2005CA2546465A1 Identification, isolation and elimination of cancer stem cells
06/23/2005CA2546130A1 Methods for identifying modulators of active kit tyrosine kinase receptor
06/23/2005CA2546126A1 Use of t-cadherin as a target
06/23/2005CA2544018A1 Compositions and methods to reduce mutagenesis
06/23/2005CA2490432A1 Cartridge for monitoring the function of a device for testing blood platelet function, method for function monitoring, and use of a test fluid
06/22/2005EP1544655A2 Patch for microarray reaction chamber having adhesive means support and two or more adhesive materials
06/22/2005EP1544634A1 In vitro method for characterizing the metabolic stability of a hyperpolarized drug candidate
06/22/2005EP1544621A1 Control plasma for thrombin activity tests